Correction: Distribution of CYP2C19 genetic polymorphisms and pharmacogenomic implications in 11,710 patients with cardiovascular and cerebrovascular conditions: a large population-based study in eastern China

The ethics statement was erroneously given as “The studies involving humans were approved by Ethics Committee Approval Letter of Biomedical Research Involving Humans. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.” The correct ethics statement is “The studies involving humans were approved by the Medical Ethics Committee of Taizhou Hospital of Zhejiang Province (Approval No. K20260129). The study was conducted in accordance with local legislation and institutional requirements.”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.